These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8103699)

  • 1. Suspected cutaneous drug toxicity in rheumatoid arthritis--an evaluation.
    Wilkinson SM; Smith AG; Davis MJ; Mattey DL; Dawes PT
    Br J Rheumatol; 1993 Sep; 32(9):798-803. PubMed ID: 8103699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis.
    van Jaarsveld CH; Jahangier ZN; Jacobs JW; Blaauw AA; van Albada-Kuipers GA; ter Borg EJ; Brus HL; Schenk Y; van Der Veen MJ; Bijlsma JW
    Rheumatology (Oxford); 2000 Dec; 39(12):1374-82. PubMed ID: 11136881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cutaneous side effects induced by D-penicillamine in the treatment of rheumatoid arthritis].
    Broggini M; Baratelli E; Cappelli A; Crespi E; Filardi PG; Volontè S
    Minerva Med; 1990 Mar; 81(3):197-201. PubMed ID: 2138721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatic syndromes caused by antirheumatic drugs.
    Rooney PJ; Bálint GP; Szebenyi B; Petrou P
    Baillieres Clin Rheumatol; 1991 Apr; 5(1):139-73. PubMed ID: 1676937
    [No Abstract]   [Full Text] [Related]  

  • 6. D-penicillamine-induced pemphigus successfully treated with combination therapy of mizoribine and prednisolone.
    Sugita K; Hirokawa H; Izu K; Tokura Y
    J Dermatolog Treat; 2004 Jul; 15(4):214-7. PubMed ID: 15764033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1994 Nov; 36(935):101-6. PubMed ID: 7968781
    [No Abstract]   [Full Text] [Related]  

  • 8. Problems of antiarthritic therapy in the elderly.
    Brooks PM; Kean WF; Kassam Y; Buchanan WW
    J Am Geriatr Soc; 1984 Mar; 32(3):229-34. PubMed ID: 6366034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
    Amasaki Y; Sagawa A; Atsumi T; Jodo S; Nakabayashi T; Watanabe I; Mukai M; Fujisaku A; Nakagawa S; Kobayashi H
    Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
    Franchimont P; Heynen G; Hauwaert CH
    J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH; Whelton A
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1991 Jul; 33(848):65-70. PubMed ID: 1676134
    [No Abstract]   [Full Text] [Related]  

  • 13. Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients.
    De La Mata J; Blanco FJ; Gómez-Reino JJ
    Ann Rheum Dis; 1995 Nov; 54(11):881-5. PubMed ID: 7492236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dosage and adverse effects of commonly used antirheumatic agents].
    Mathies H
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):320-6. PubMed ID: 5317064
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinicopathological study of nephropathy in patients with rheumatoid arthritis].
    Yoshida A; Morozumi K; Suganuma T; Aoki J; Sugito K; Koyama K; Oikawa T; Fujinimi T; Matsumoto Y
    Ryumachi; 1991 Feb; 31(1):14-21. PubMed ID: 1677490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous reactions to rheumatological drugs.
    Bailin PL; Matkaluk RM
    Clin Rheum Dis; 1982 Aug; 8(2):493-516. PubMed ID: 6216041
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary disease due to antirheumatic agents.
    Zitnik RJ; Cooper JA
    Clin Chest Med; 1990 Mar; 11(1):139-50. PubMed ID: 1969788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Superficial pemphigus during the treatment of rheumatoid polyarthritis with D-penicillamine and piroxicam (Feldene)].
    Piette-Brion B; de Bast C; Chamoun E; de Dobbeleer G; André J; Huybrechts A; Ledoux M; Achten G
    Dermatologica; 1985; 170(6):297-301. PubMed ID: 4018339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cutaneous reactions to gold salts].
    Bonnetblanc JM
    Presse Med; 1996 Oct; 25(32):1555-8. PubMed ID: 8952665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid arthritis therapy: the risk/benefit ratio.
    Bellows JG
    Compr Ther; 1978 Aug; 4(8):3-4. PubMed ID: 308431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.